We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
–
AUM
$144B
AUM Growth
+$590M
Cap. Flow
-$2.29B
Cap. Flow %
-1.6%
Top 10 Hldgs %
13.5%
Holding
3,177
New
29
Increased
1,134
Reduced
1,491
Closed
61

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$397M
2
CSCO icon
Cisco
CSCO
+$234M
3
PFE icon
Pfizer
PFE
+$177M
4
CXO
CONCHO RESOURCES INC.
CXO
+$172M
5
COL
Rockwell Collins
COL
+$162M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$400M
2
MSFT icon
Microsoft
MSFT
+$308M
3
JNJ icon
Johnson & Johnson
JNJ
+$253M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$240M
5
ALKS icon
Alkermes
ALKS
+$202M

Sector Composition

Rank Sector Weight
1 Technology 15.4%
2 Healthcare 15.35%
3 Financials 13.37%
4 Industrials 10.65%
5 Consumer Discretionary 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIA
3051
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$222K ﹤0.01%
6,029
+2,620
+77% +$95.4K
MDLY
3052
DELISTED
Medley Management Inc
MDLY
$222K ﹤0.01%
2,021
+5
+0.2% +$570
GTE icon
3053
Gran Tierra Energy
GTE
$317M
$218K ﹤0.01%
+8,000
New +$217K
AKAO
3054
DELISTED
Achaogen Inc
AKAO
$216K ﹤0.01%
22,168
– –
GEG icon
3055
Great Elm Group
GEG
$69.3M
$215K ﹤0.01%
31,380
– –
VERU icon
3056
Veru
VERU
$37.4M
$211K ﹤0.01%
7,469
– –
TIPT icon
3057
Tiptree Inc
TIPT
$675M
$209K ﹤0.01%
31,454
– –
GALT icon
3058
Galectin Therapeutics
GALT
$348M
$208K ﹤0.01%
62,037
– –
ATEN icon
3059
A10 Networks
ATEN
$1.95B
$202K ﹤0.01%
46,724
+7,277
+18% +$33.3K
CIFC
3060
DELISTED
CIFC LLC Common Shares
CIFC
$200K ﹤0.01%
26,115
– –
VTAE
3061
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$197K ﹤0.01%
16,801
+5,174
+44% +$69.8K
HIVE
3062
DELISTED
Aerohive Networks
HIVE
$191K ﹤0.01%
42,878
– –
NEFF
3063
DELISTED
Neff Corporation
NEFF
$190K ﹤0.01%
18,048
+13,623
+308% +$133K
NBSE
3064
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$185K ﹤0.01%
182
– –
ESI
3065
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
$184K ﹤0.01%
27,067
– –
RVLT
3066
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$183K ﹤0.01%
16,506
– –
LEAF
3067
DELISTED
Leaf Group Ltd.
LEAF
$174K ﹤0.01%
30,337
+131
+0.4% +$672
CRCM
3068
DELISTED
CARE.COM, INC.
CRCM
$173K ﹤0.01%
22,768
– –
GNCA
3069
DELISTED
Genocea Biosciences, Inc.
GNCA
$173K ﹤0.01%
1,823
– –
MBII
3070
DELISTED
Marrone Bio Innovations, Inc.
MBII
$170K ﹤0.01%
43,898
– –
ADMS
3071
DELISTED
Adamas Pharmaceuticals
ADMS
$166K ﹤0.01%
9,497
– –
VRNG
3072
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
$165K ﹤0.01%
25,424
– –
VCYT icon
3073
Veracyte
VCYT
$3.8B
$162K ﹤0.01%
22,315
– –
CARM
3074
DELISTED
Carisma Therapeutics
CARM
$161K ﹤0.01%
903
– –
RLOC
3075
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$149K ﹤0.01%
51,225
– –
121 122
123
124 125

Similar funds

TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
SBAM
Santa Barbara Asset Management Los Angeles, California $6.43B AUM 10.99% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SA
SQ Advisors Naples, Florida $1.32B AUM 10.3% 1-Year Est. Return
WF
WealthTrust Fairport Cleveland, Ohio $1.06B AUM 3.47% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

TIAA CREF Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, TIAA CREF Investment Management held 3,177 positions worth $144B, up 0.41% from $143B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2015: portfolio turnover was 2.8%. TIAA CREF Investment Management opened 29 new positions and exited 61, leaving the 3,177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • TIAA CREF Investment Management's largest Q1 2015 buy was Columbia Pipeline Partners LP: 3,302,169 shares worth $91.4M.
  • TIAA CREF Investment Management added most to Allergan plc in Q1 2015, an estimated $397M increase.
  • TIAA CREF Investment Management's biggest Q1 2015 reduction was Microsoft, cutting an estimated $308M.
  • TIAA CREF Investment Management fully exited Allergan Inc in Q1 2015, selling an estimated $400M.
  • TIAA CREF Investment Management's ten largest holdings make up 14% of its $144B portfolio in Q1 2015.
  • TIAA CREF Investment Management opened 29 new positions and closed 61 in Q1 2015.
  • TIAA CREF Investment Management's portfolio value rose 0.41% quarter-over-quarter to $144B.

Based on TIAA CREF Investment Management's 13F filing for Q1 2015, filed 5 May 2015.